| Entry |
|
| Name |
Serotonergic synapse
|
| Description |
Serotonin (5-Hydroxytryptamine, 5-HT) is a monoamine neurotransmitter that plays important roles in physiological functions such as learning and memory, emotion, sleep, pain, motor function and endocrine secretion, as well as in pathological states including abnormal mood and cognition. Once released from presynaptic axonal terminals, 5-HT binds to receptors, which have been divided into 7 subfamilies on the basis of conserved structures and signaling mechanisms. These families include the ionotropic 5-HT3 receptors and G-protein-coupled 5-HT receptors, the 5-HT1 (Gi /Go -coupled), 5-HT2(Gq-coupled), 5-HT4/6/7 (Gs-coupled) and 5-HT5 receptors. Presynaptically localized 5-HT1B receptors are thought to be the autoreceptors that suppress excess 5-HT release. 5-HT's actions are terminated by transporter- mediated reuptake into neurons, leading to catabolism by monoamine oxidase.
|
| Class |
Organismal Systems; Nervous system
 |
| Pathway map |

  |
| Disease |
| Neurodegeneration with brain iron accumulation (NBIA) | | Aromatic L-amino acid decarboxylase (AADC) deficiency | | Cerebral amyloid angiopathy (CAA) |
|
| Other DBs |
|
| Orthology |
| | | aromatic-L-amino-acid decarboxylase [EC: 4.1.1.28] | | MFS transporter, DHA1 family, solute carrier family 18 (vesicular amine transporter), member 1/2 | | voltage-dependent calcium channel L type alpha-1C | | voltage-dependent calcium channel L type alpha-1D | | voltage-dependent calcium channel L type alpha-1F | | voltage-dependent calcium channel L type alpha-1S | | 5-hydroxytryptamine receptor 2 | | guanine nucleotide-binding protein G(q) subunit alpha | | phosphatidylinositol phospholipase C, beta [EC: 3.1.4.11] | | inositol 1,4,5-triphosphate receptor type 1 | | inositol 1,4,5-triphosphate receptor type 2 | | inositol 1,4,5-triphosphate receptor type 3 | | | | extracellular signal-regulated kinase 1/2 [EC: 2.7.11.24] | | cytosolic phospholipase A2 [EC: 3.1.1.4] | | cytochrome P450, family 2, subfamily C [EC: 1.14.14.1] | | cytochrome P450, family 2, subfamily D [EC: 1.14.14.1] | | cytochrome P450, family 2, subfamily J [EC: 1.14.14.1] | | cytochrome P450, family 4, subfamily X [EC: 1.14.14.1] | | | | | | arachidonate 12-lipoxygenase (R-type) [EC:1.13.11.-] | | | | arachidonate 15-lipoxygenase (second type) / 8-lipoxygenase (S-type) [EC:1.13.11.- 1.13.11.33] | | prostaglandin-endoperoxide synthase 1 [EC: 1.14.99.1] | | prostaglandin-endoperoxide synthase 2 [EC: 1.14.99.1] | | 5-hydroxytryptamine receptor 3 | | 5-hydroxytryptamine receptor 4 | | 5-hydroxytryptamine receptor 6 | | 5-hydroxytryptamine receptor 7 | | guanine nucleotide-binding protein G(s) subunit alpha | | | | | | potassium intermediate/small conductance calcium-activated channel subfamily N member 2 | | potassium voltage-gated channel Shal-related subfamily D member 2 | | gamma-aminobutyric acid receptor subunit beta | | Rap guanine nucleotide exchange factor (GEF) 3 | | amyloid beta A4 protein | | 5-hydroxytryptamine receptor 1 | | 5-hydroxytryptamine receptor 5 | | guanine nucleotide-binding protein G(i) subunit alpha | | guanine nucleotide-binding protein G(o) subunit alpha | | guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | | guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 | | guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 | | guanine nucleotide-binding protein subunit beta-4 | | guanine nucleotide-binding protein subunit beta-5 | | guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 | | guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3 | | guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4 | | guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | | guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7 | | guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 | | guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | | guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11 | | guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 | | guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13 | | guanine nucleotide-binding protein G(T) subunit gamma-T1 | | guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 | | | | GTPase HRas | | GTPase KRas | | GTPase NRas | | A-Raf proto-oncogene serine/threonine-protein kinase [EC: 2.7.11.1] | | B-Raf proto-oncogene serine/threonine-protein kinase [EC: 2.7.11.1] | | RAF proto-oncogene serine/threonine-protein kinase [EC: 2.7.11.1] | | mitogen-activated protein kinase kinase 1 [EC: 2.7.12.2] | | voltage-dependent calcium channel P/Q type alpha-1A | | voltage-dependent calcium channel N type alpha-1B | | potassium inwardly-rectifying channel subfamily J member 3 | | potassium inwardly-rectifying channel subfamily J member 6 | | potassium inwardly-rectifying channel subfamily J member 9 | | potassium inwardly-rectifying channel subfamily J member 5 | | transient receptor potential cation channel subfamily C member 1 | | solute carrier family 6 (neurotransmitter transporter, serotonin) member 4 | | |
|
| Compound |
| Calcium cation | | L-Tryptophan | | Diacylglycerol | | Arachidonate | | Potassium cation | | Prostaglandin H2 | | 3',5'-Cyclic AMP | | Prostaglandin E2 | | Prostaglandin F2alpha | | 5-Hydroxy-L-tryptophan | | Prostaglandin D2 | | Serotonin | | Leukotriene A4 | | D-myo-Inositol 1,4,5-trisphosphate | | Sodium cation | | Leukotriene B4 | | Leukotriene C4 | | Thromboxane A2 | | 8(R)-HPETE | | 5(S)-HPETE | | 5-Hydroxyindoleacetate | | Prostaglandin A2 | | Prostaglandin B2 | | Prostaglandin C2 | | Prostaglandin G2 | | Prostaglandin J2 | | Thromboxane B2 | | 11-Dehydro-thromboxane B2 | | 12(S)-HPETE | | 15(S)-HPETE | | 5,6-EET | | 8,9-EET | | 11,12-EET | | 14,15-EET | | 5,6-DHET | | 8,9-DHET | | 11,12-DHET | | 14,15-DHET | | 12(R)-HPETE | | 11(R)-HPETE | | 9(S)-HPETE | | 8(S)-HPETE |
|
| Reference |
|
| Authors |
Millan MJ, Marin P, Bockaert J, Mannoury la Cour C |
| Title |
Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions. |
| Journal |
Trends Pharmacol Sci 29:454-64 (2008) |
| Reference |
|
| Authors |
Bockaert J, Claeysen S, Becamel C, Dumuis A, Marin P |
| Title |
Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation. |
| Journal |
Cell Tissue Res 326:553-72 (2006) |
| Reference |
|
| Authors |
Raymond JR, Mukhin YV, Gelasco A, Turner J, Collinsworth G, Gettys TW, Grewal JS, Garnovskaya MN |
| Title |
Multiplicity of mechanisms of serotonin receptor signal transduction. |
| Journal |
Pharmacol Ther 92:179-212 (2001) |
| Reference |
|
| Authors |
Noda M, Higashida H, Aoki S, Wada K |
| Title |
Multiple signal transduction pathways mediated by 5-HT receptors. |
| Journal |
Mol Neurobiol 29:31-9 (2004) |
| Reference |
|
| Authors |
Daubert EA, Condron BG |
| Title |
Serotonin: a regulator of neuronal morphology and circuitry. |
| Journal |
Trends Neurosci 33:424-34 (2010) |
| Reference |
|
| Authors |
Chameau P, van Hooft JA |
| Title |
Serotonin 5-HT(3) receptors in the central nervous system. |
| Journal |
Cell Tissue Res 326:573-81 (2006) |
| Reference |
|
| Authors |
Tournois C, Mutel V, Manivet P, Launay JM, Kellermann O |
| Title |
Cross-talk between 5-hydroxytryptamine receptors in a serotonergic cell line. Involvement of arachidonic acid metabolism. |
| Journal |
J Biol Chem 273:17498-503 (1998) |
| Reference |
|
| Authors |
Iliff JJ, Jia J, Nelson J, Goyagi T, Klaus J, Alkayed NJ |
| Title |
Epoxyeicosanoid signaling in CNS function and disease. |
| Journal |
Prostaglandins Other Lipid Mediat 91:68-84 (2010) |
| Reference |
|
| Authors |
Adayev T, Ray I, Sondhi R, Sobocki T, Banerjee P |
| Title |
The G protein-coupled 5-HT1A receptor causes suppression of caspase-3 through MAPK and protein kinase Calpha. |
| Journal |
Biochim Biophys Acta 1640:85-96 (2003) |
| Reference |
|
| Authors |
Albert PR, Tiberi M |
| Title |
Receptor signaling and structure: insights from serotonin-1 receptors. |
| Journal |
Trends Endocrinol Metab 12:453-60 (2001) |
| Reference |
|
| Authors |
Durham PL, Russo AF |
| Title |
Serotonergic repression of mitogen-activated protein kinase control of the calcitonin gene-related peptide enhancer. |
| Journal |
Mol Endocrinol 12:1002-9 (1998) |
| Reference |
|
| Authors |
Robert S, Maillet M, Morel E, Launay JM, Fischmeister R, Mercken L, Lezoualc'h F |
| Title |
Regulation of the amyloid precursor protein ectodomain shedding by the 5-HT4 receptor and Epac. |
| Journal |
FEBS Lett 579:1136-42 (2005) |
| Reference |
|
| Authors |
Lezoualc'h F, Robert SJ |
| Title |
The serotonin 5-HT4 receptor and the amyloid precursor protein processing. |
| Journal |
Exp Gerontol 38:159-66 (2003) |
| Reference |
|
| Authors |
Durham PL, Russo AF |
| Title |
Differential regulation of mitogen-activated protein kinase-responsive genes by the duration of a calcium signal. |
| Journal |
Mol Endocrinol 14:1570-82 (2000) |
| Reference |
|
| Authors |
Hagberg GB, Blomstrand F, Nilsson M, Tamir H, Hansson E |
| Title |
Stimulation of 5-HT2A receptors on astrocytes in primary culture opens voltage-independent Ca2+ channels. |
| Journal |
Neurochem Int 32:153-62 (1998) |
| Reference |
|
| Authors |
Nestler EJ, Hyman SE, Malenka RC. |
| Title |
Molecular neuropharmacology: A foundation for clinical neuroscience |
| Journal |
The McGraw-Hill Companies, Inc. (2001) |